Keytruda subkutan 395 mg/2.4 ml
Keytruda subkutan 395 mg/2.4 ml is a medicine authorised by Swissmedic under authorisation number 70253. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 01 June 2026 and the authorisation is limited until 31 May 2031. ATC code L01FF02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 70253 |
|---|---|
| Name | Keytruda subkutan 395 mg/2.4 ml |
| Full name | Keytruda subkutan 395 mg/2.4 ml, Injektionslösung |
| Authorisation holder | MSD Merck Sharp & Dohme AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FF02 |
| First authorisation | 01 June 2026 |
| Authorisation validity | 31 May 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Keytruda subkutan 395 mg/2.4 ml, Injektionslösung | A | 01 June 2026 |
| 2 | Keytruda subkutan 790 mg/4.8 ml, Injektionslösung | A | 01 June 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FF02 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FF02 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Keytruda subkutan 395 mg/2.4 ml authorised in Switzerland?
Yes. Keytruda subkutan 395 mg/2.4 ml is authorised by Swissmedic under authorisation number 70253, data as of 01 September 2026. The authorisation is limited until 31 May 2031.
Which dispensing category does Keytruda subkutan 395 mg/2.4 ml have?
Keytruda subkutan 395 mg/2.4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Keytruda subkutan 395 mg/2.4 ml?
The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.